Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucagon-like Peptide-1 Receptor Agonists as Novel Pharmacotherapies for Nicotine Dependence

NCT03712098 is registered in ClinicalTrials.gov with Rebecca Ashare as lead sponsor.

NCT NCT03712098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03712098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucagon-like Peptide-1 Receptor Agonists as Novel Pharmacotherapies for Nicotine Dependence
Lead sponsor
Rebecca Ashare
Phase
Phase 2
Overall status
Completed
Start date
November 29, 2018
Completion date
May 25, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation, weight, body